AcquisitionOther
Rallybio Corporation acquired Avenzo Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Rallybio Corporation -> Avenzo Therapeutics, Inc. · $215 million
Advance next-generation oncology therapies portfolio through merger and concurrent financing.
Open source record (SEC) ↗